相关实验视频
Updated: Jun 13, 2025

10:12
Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
Published on: March 25, 2020
6.0K
对尼曼-皮克C1疾病的潜在治疗方法的研究进展
Caifeng Zhang1, Keke Su1,2, Xu Jiang1,2
1Department of Gastroenterology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Frontiers in pharmacology
|September 12, 2024
概括
尼曼-皮克病C1型 (NP-C1) 是一种罕见的遗传疾病,影响胆固醇运输. 目前的研究探讨了各种治疗策略,包括小分子,细胞疗法和基因疗法,以对抗这种疾病.
科学领域:
- 遗传学和分子生物学
- 溶酶体储存障碍 溶酶体储存障碍
- 神经退行性疾病 神经退行性疾病
背景情况:
- 尼曼-皮克病C1型 (NP-C1) 是一种罕见的,遗传的溶酶体脂质和胆固醇储存障碍.
- 它是由NPC1或NPC2基因的突变引起的,它破坏了内体内胆固醇的运输.
- 临床特征包括肝炎扩大,神经退行和性衰竭.
研究的目的:
- 为尼曼·皮克病C1型提供当前和新兴治疗策略的概述.
- 突出开发治疗这种罕见疾病的挑战.
- 讨论正在研究的各种理论治疗方法.
主要方法:
- 对NP-C1.1.的现有文献的审查.
- 分析不同的治疗方式,包括小分子疗法,基于细胞的方法和基因疗法.
- 讨论临床前和临床开发中的挑战.
主要成果:
- 在过去的二十年中,许多潜在的治疗方法已经开发出来.
- 这些疗法主要是在动物或临床实验阶段.
- 小分子,基于细胞和基因疗法看起来有前途,但面临重大障碍.
结论:
- 尽管NP-C1的稀有性带来了挑战,但正在进行的研究正在产生各种治疗策略.
- 需要进一步开发和临床验证才能将这些治疗方法带给患者.
- 对于有效的NP-C1管理,可能需要结合不同疗法的多方面的方法.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
154
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
154

